companydata.dkcompanydata.dk

Alveus Therapeutics ApS: Financial statements 2024

CVR: 44689790

Source: annual report 2024, Danish Business Authority

05/03/2024 – 31/12/2024

Alveus Therapeutics ApS (CVR 44689790) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -968,913 and a net result of DKK -5,608,478. Equity in the 2024 report amounted to DKK -5,568,478. The company had 3 employees in the financial year.

Gross Profit
DKK -968,913
Profit/Loss
DKK -5,608,478
Equity
DKK -5,568,478
Total Assets
DKK 479,987
Employees
3

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

Marie Louise Lindegaard joins Alveus Therapeutics ApS as directorDec 11, 2024

As of December 11, 2024, Marie Louise Lindegaard is registered as director of Alveus Therapeutics ApS.

Lars Peter Brunse steps down as director of Alveus Therapeutics ApSDec 11, 2024

As of December 11, 2024, Lars Peter Brunse has stepped down as director of Alveus Therapeutics ApS.

Lars Peter Brunse joins Alveus Therapeutics ApS as directorMar 5, 2024

As of March 5, 2024, Lars Peter Brunse is registered as director of Alveus Therapeutics ApS.

Nayan Gregory Parekh joins Alveus Therapeutics ApS as adm. dir.Mar 5, 2024

As of March 5, 2024, Nayan Gregory Parekh is registered as adm. dir. of Alveus Therapeutics ApS.

Alveus Therapeutics ApS is foundedMar 5, 2024

Alveus Therapeutics ApS was founded on March 5, 2024.

About Alveus Therapeutics ApS

Alveus Therapeutics ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2024. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Rajkumar Kannan. The company's owners include Novo Holdings A/S, Alveus Therapeutics Inc. and FPCI BioDiscovery 7. The company has 12 employees (2026). In 2025, the company reported a gross profit of DKK 22,056,673 and a net result of DKK 2,096,582 compared with DKK -5,608,478 the year before. Equity in the 2025 report amounted to DKK 59,681,194.

Source: annual report 2025, Danish Business Authority

Other financial years